Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Tandem Diabetes Care reported $95.87M in Cost of Sales for its fiscal quarter ending in September of 2023.

Cost Of Sales Change Date
Abbott USD 4.61B 122M Sep/2023
Accuray USD 64.4M 16.22M Sep/2023
Align Technology USD 297.14M 8.57M Sep/2023
AtriCure USD 24.42M 580K Sep/2023
Baxter International USD 2.57B 237M Sep/2023
Becton, Dickinson and Co. USD 3.39B 608M Sep/2023
Boston Scientific USD 1.11B 62M Sep/2023
Cooper Companies USD 320.6M 400K Sep/2023
Dexcom USD 351.7M 26.8M Sep/2023
Edwards Lifesciences USD 350.4M 7.4M Sep/2023
Eli Lilly USD 1.86B 52.7M Sep/2023
Globus Medical USD 135.39M 58.92M Sep/2023
ICU Medical USD 369.39M 12.41M Sep/2023
Inogen USD 50.2M 612K Sep/2023
Insulet USD 139.4M 7.8M Sep/2023
Integra LifeSciences USD 128.25M 12.84M Sep/2023
Intuitive Surgical USD 576.5M 7.5M Sep/2023
J&J USD 6.61B 1.61B Sep/2023
Masimo USD 244.1M 10M Sep/2023
Merit Medical Systems USD 173.03M 5.76M Sep/2023
Orthofix International USD 64.24M 3.22M Sep/2023
Roche Holding CHF 7.62B 1.33B Jun/2023
Stryker USD 1.73B 75M Sep/2023
Tandem Diabetes Care USD 95.87M 1.69M Sep/2023
Teleflex USD 330.08M 5.36M Sep/2023
Zimmer Biomet Holdings USD 518.6M 6.9M Sep/2023